LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017.
|
30055862 |
2018 |
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G (disorder)
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G).
|
24647604 |
2014 |
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G (disorder)
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G).
|
24647604 |
2014 |
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G (disorder)
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G (disorder)
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G (disorder)
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Muscular Dystrophies, Limb-Girdle
|
0.450 |
GeneticVariation
|
group |
BEFREE |
To date, LGMD D3 (previously known as LGMD1G) has been characterized in only two families with Brazilian or Uruguayan origin.
|
30604053 |
2019 |
Muscular Dystrophies, Limb-Girdle
|
0.450 |
Biomarker
|
group |
BEFREE |
Mutation of aspartic acid 378 of hnRNPDL to either asparagine or histidine has been associated with limb girdle muscular dystrophy.
|
30279180 |
2018 |
Muscular Dystrophies, Limb-Girdle
|
0.450 |
Biomarker
|
group |
GENOMICS_ENGLAND |
229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017.
|
30055862 |
2018 |
Muscular Dystrophies, Limb-Girdle
|
0.450 |
Biomarker
|
group |
BEFREE |
HNRPDL is linked to the development of limb-girdle muscular dystrophy 1G and shares domain architecture with TDP-43.
|
26160665 |
2015 |
Muscular Dystrophies, Limb-Girdle
|
0.450 |
Biomarker
|
group |
BEFREE |
A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G).
|
24647604 |
2014 |
Muscular Dystrophies, Limb-Girdle
|
0.450 |
GeneticVariation
|
group |
BEFREE |
The LGMD group is still growing today and consists of 19 autosomal dominant and recessive forms (LGMD1A to LGMD1G and LGMD2A to LGMD2M).
|
17339125 |
2007 |
Muscular Dystrophies, Limb-Girdle
|
0.450 |
Biomarker
|
group |
HPO |
|
|
|
Myopathy
|
0.110 |
Biomarker
|
group |
BEFREE |
The present study enlarges the clinical, morphological and muscle MRI spectrum of AD-HNRNPDL-related myopathies demonstrating the significant particularities of the disease.
|
31267206 |
2019 |
Myopathy
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Cataract
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hyporeflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Creatine phosphokinase serum increased
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Shoulder girdle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Pelvic girdle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Proximal lower limb amyotrophy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Decreased movement range in interphalangeal joints
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Rimmed vacuoles on biopsy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Slow progression
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Proximal upper limb amyotrophy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|